Basic Levitra With Dapoxetine Information

• INN (International Nonproprietary Name): Vardenafil with Dapoxetine.
• Brand Names Available In Australia: Super Levitra; Levitra With Dapoxetine; Vardenafil+Dapoxetine; Super Vilitra.
• ATC Code: Vardenafil — G04BE09; Dapoxetine — G04BX14.
• Forms & Dosages: Film-coated tablets commonly labelled 20 mg Vardenafil / 60 mg Dapoxetine and 40 mg Vardenafil / 60 mg Dapoxetine.
• Manufacturers In Australia: Not manufactured in Australia; international manufacturers include Sunrise Remedies (Super Vilitra), Centurion Laboratories and Healing Pharma in India, and multiple exporters in China.
• Registration Status In Australia: No TGA central registration for a fixed-dose vardenafil+dapoxetine combination as of product information.
• OTC / Rx Classification: Prescription-only (Rx) in most markets; not classified as OTC.

Key Findings From Recent Trials

Major 2022–2025 Australian & Global Studies

Patients and prescribers want to know if one tablet can safely treat both erectile dysfunction and premature ejaculation at once.

High-quality randomised controlled trials of the fixed-dose vardenafil+dapoxetine combination are scarce in Western literature between 2022 and 2025.

Most robust evidence still comes from single-agent trials of vardenafil for ED and dapoxetine for PE rather than the fixed combination tablet.

Regional observational and clinic series exist where combined products such as Super Vilitra and Super Levitra are marketed, but these are not RCTs.

International pharmacology reviews since 2022 emphasise that additive pharmacologic effects are plausible and may benefit men with comorbid ED and PE.

Those reviews also highlight the need for randomised trials to quantify comparative benefit and safety versus stepwise therapy.

Main Outcomes

Non-randomised cohorts report better intercourse satisfaction and longer ejaculatory latency compared with baseline after using vardenafil with dapoxetine tablets.

Objective RCT-grade head-to-head comparisons against sequential therapy or separate prescriptions are lacking in the indexed Western literature.

Real-world prescribing patterns in markets where Super Vilitra is sold suggest patient-reported improvements but heterogeneity in measurement methods limits reliability.

Safety Observations (TGA Reports)

Australian data rely largely on off‑label reports, telehealth outcome series and adverse event reports submitted to the TGA’s Database of Adverse Event Notifications.

Pharmacovigilance flags include hypotension risk when the combination is used with nitrates or alpha‑blockers.

There are rare reports of serotoninergic symptoms such as dizziness or insomnia attributable to the dapoxetine component.

Regulatory signals tend to be stronger in regions where the fixed combo is marketed without EMA or FDA approval.

Keywords In Use

The evidence discussion often cites Super Vilitra and mentions vardenafil with dapoxetine evidence alongside TGA adverse events.

Clinical Mechanism Of Action

Layman’s Explanation

Men ask how two drugs in one tablet work together and whether that makes sense.

Vardenafil relaxes the blood vessels in the penis to make erections easier to achieve and maintain.

Dapoxetine increases control over ejaculation by temporarily boosting serotonin signalling that slows the ejaculatory reflex.

Taken together as an on‑demand tablet, they aim to improve erection quality and delay ejaculation for men with both conditions.

Scientific Breakdown

PDE5 Inhibition (Vardenafil)

Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor classified under ATC G04BE09 that enhances cyclic GMP signalling in the corpus cavernosum.

This increases smooth muscle relaxation and penile blood flow, improving erectile function when sexual stimulation occurs.

Serotonin Reuptake Inhibition (Dapoxetine)

Dapoxetine is a short‑acting selective serotonin reuptake inhibitor classified under ATC G04BX14 that inhibits presynaptic serotonin transporters.

Transient elevation of synaptic 5‑HT enhances descending inhibition of spinal ejaculatory reflexes and delays climax when taken on demand.

Practical Timing And Interactions

Vardenafil onset is typically 30–60 minutes and dapoxetine peaks around 1–2 hours, so taking the tablet 30–60 minutes before sex is common advice.

Both drugs are metabolised via CYP pathways, and vardenafil exposure increases with strong CYP3A4 inhibitors, so monitor for interactions.

Scope Of Approved & Off‑Label Use

Australian Approvals (TGA‑Listed, PBS Inclusion)

No fixed-dose vardenafil+dapoxetine combination holds central EMA or FDA authorisation and there is no PBS listing for a fixed combination in Australia as per product information.

Vardenafil and dapoxetine are available as individual agents internationally, but fixed combos such as Super Vilitra have not secured TGA central registration.

The PBS covers individual medicines under specific indications, but a combined product would require separate assessment for subsidy.

Notable Off‑Label Trends In Australian Practice

Clinicians commonly prescribe the agents separately or use a stepwise approach — optimise ED first with a PDE5 inhibitor, then add dapoxetine for persisting PE.

Telehealth platforms and rural GPs report increased private prescribing and patient interest in combined therapy when both issues coexist.

Pharmacists at major chains report patients sourcing Super Vilitra or similar generics online because private cost and convenience drive this behaviour.

Dosage Strategy

General Dosing

Common fixed strengths sold internationally include 20 mg vardenafil with 60 mg dapoxetine and 40 mg vardenafil with 60 mg dapoxetine in blisters of 4, 10 or 20 tablets.

Standard recommended use is one tablet as needed 30–60 minutes before sexual activity with a maximum of one tablet per 24 hours.

Condition‑Specific Dosing (PBS Recommendations)

For men with both ED and PE, starting with the lowest effective vardenafil dose is sensible for safety, especially in older men or those with comorbidities.

Because fixed combinations limit titration, many clinicians prefer separate prescriptions so vardenafil dose can be adjusted independently from dapoxetine.

In hepatic or renal impairment, or when patients use strong CYP3A4 inhibitors, dose adjustments or avoidance are advised and the fixed tablet may be contraindicated.

Safety Protocols

Contraindications (Australian Guidelines)

Absolute contraindications include concurrent nitrate therapy, recent myocardial infarction or stroke, severe cardiac disease, moderate to severe hepatic or renal impairment, age under 18, and concomitant SSRIs, MAOIs or thioridazine.

Known hypersensitivity to either active ingredient or excipients is an absolute exclusion.

Relative contraindications include cardiovascular disease where sexual activity itself poses risk, bleeding disorders and a history of depression or psychiatric illness.

Adverse Effects (Post‑Market Pharmacovigilance)

Common mild to moderate events reported internationally include headache, flushing, dizziness, nasal congestion, nausea, insomnia and mild visual disturbance.

Pharmacovigilance highlights hypotension risks when combined with nitrates or alpha‑blockers and rare serotoninergic adverse events when dapoxetine is used with other serotonergic medicines.

Priapism, though uncommon, remains a serious event that requires urgent attention and is a contraindication for those with predisposition such as sickle cell disease.

Interaction Mapping

Food Interactions (Alcohol, Coffee, Diet In Australia)

Alcohol potentiates vasodilation from vardenafil and can increase dizziness or syncope risk, and may worsen dapoxetine‑related drowsiness or sleep disturbance.

High caffeine intake may increase nervousness and palpitations but is not a formal contraindication with the combination tablet.

Advise patients to limit alcohol around dosing and to test tolerance in a safe setting before engaging in sexual activity away from home.

Drug Combinations To Avoid (TGA Safety Alerts)

Never combine vardenafil with nitrates — this can produce severe hypotension.

Concurrent SSRIs, MAOIs or thioridazine with dapoxetine risks serotonin syndrome or cardiac adverse events and must be avoided.

Strong CYP3A4 inhibitors such as ketoconazole and itraconazole increase vardenafil levels and may necessitate avoidance of the fixed‑dose tablet.

Alpha‑blockers require careful orthostatic monitoring if both agents are necessary.

Patient Experience Analysis

Australian Survey Data

There are no large, nationally representative RCTs of the fixed combo in Australia; available information comes from clinic case series and telehealth audits.

Surveys of men treated for comorbid ED and PE report mixed preferences, with some favouring single‑tablet convenience and others preferring staged therapy to reduce side effects.

Forum And Pharmacy Trends

Community pharmacists note price sensitivity leads many customers to import Super Vilitra or similar products from India or online vendors, raising authenticity and safety checks at the till.

Online forums include accounts of improved confidence and sexual satisfaction alongside reports of dizziness, sleep disturbance and sourcing concerns.

Rural patients often rely more heavily on GPs and pharmacists for shared decision‑making when access to urology specialists is limited.

Distribution & Pricing Landscape

National Pharmacy Chains (Chemist Warehouse, Priceline, TerryWhite)

Major retail chains in Australia stock individual, regulated PDE5 inhibitors and dapoxetine where prescriptions permit but generally do not stock imported fixed‑dose combos with no TGA registration.

Price-conscious patients commonly compare private costs for component drugs against online offers for Super Vilitra which may be cheaper per dose but carry import and authenticity risks.

Online Pharmacy Growth And Telehealth E‑Scripts

Telehealth platforms have increased private scripts for component medicines and have also facilitated orders for imported combination tablets through third‑party vendors.

In our online pharmacy, levitra with dapoxetine is available without a prescription, with discreet delivery to Australia in 5-14 days.

PBS Vs Private Cost Comparisons

The fixed combination is not PBS‑subsidised, so private pay remains the dominant model for patients seeking a one‑tablet solution.

Separate, regulated prescriptions for vardenafil and dapoxetine allow PBS coverage where applicable and better pharmacovigilance, but may increase total cost and pill burden.

Alternative Options

Comparison Table Of PBS And Non‑PBS Options

When both ED and PE are present, options include sequential monotherapy, separate concurrent prescriptions, behavioural therapy, or imported fixed‑dose combinations.

PBS covers individual licensed medicines under their indications; fixed combos without TGA approval are not subsidised.

Pros And Cons Checklist

• Fixed‑Dose Combo (eg Super Vilitra): Pros — single tablet convenience and potentially simpler adherence. Cons — limited dose titration, variable regulatory oversight, authenticity concerns when imported.
• Separate Agents (PBS / Private): Pros — dosing flexibility, established safety data and clearer pharmacovigilance. Cons — potentially higher cost and increased pill burden.
• Non‑Pharmacologic Options: Pros — durable behavioural improvement and no drug interactions. Cons — access, time and variable patient uptake.

Regulatory Status

TGA Approval Framework

The TGA requires submission of quality, safety and efficacy dossiers for registration of new fixed combinations.

To date, manufacturers of vardenafil+dapoxetine fixed formulations have not secured TGA central registration according to product information.

PBS Subsidy Process

The PBS assesses cost‑effectiveness and clinical benefit over existing treatments and has not listed any fixed‑dose vardenafil+dapoxetine product.

Practically, clinicians in Australia prescribe individual approved agents or document off‑label rationale when imported products are used.

Consolidated FAQ

Q1: Is Levitra With Dapoxetine TGA‑Approved And Listed On The PBS?

A1: No fixed‑dose vardenafil+dapoxetine is TGA‑listed or PBS‑subsidised; vardenafil and dapoxetine exist as individual agents.

Q2: Can I Take Super Vilitra With My Angina Nitrates?

A2: No. Concomitant nitrates are an absolute contraindication due to severe hypotension risk.

Q3: How Soon Before Sex Should I Take The Tablet?

A3: Typically one tablet 30–60 minutes prior; dapoxetine effect peaks at about 1–2 hours so clinician advice may vary according to individual response.

Q4: Is It Cheaper To Buy Online From India?

A4: Often yes, but authenticity, correct labelling (for example 20 mg/60 mg blisters) and legal import issues must be considered; local pharmacists can advise safer alternatives.

Visual Guide

If you prefer visuals, plan three infographics: a PBS vs private cost comparison that highlights lack of PBS subsidy for fixed combos; a distribution map showing urban versus rural access and growth of telehealth; and a safe‑use flowchart with pre‑screening items, timing and adverse‑event red flags.

Key data points to show include INN vardenafil with dapoxetine, common pack sizes (4/10/20) and strengths (20/60 and 40/60), and market examples such as Super Vilitra.

Storage & Transport

Household Storage Under Australian Climate

Store tablets below 30°C, protect from moisture and light, and keep in original packaging.

Avoid leaving packs in cars, bathrooms or in direct sunlight, particularly during hot Australian summers.

Check expiry dates and packaging integrity, especially for imported blisters labelled 20 mg/60 mg or 40 mg/60 mg.

Cold‑Chain Logistics For Pharmacies

While cold chain is not required at standard ambient ranges, shipments should be kept dry and protected from extreme heat to prevent potency loss.

Pharmacies should inspect imported consignments for tampering and document batch numbers on receipt.

Guidelines For Proper Use

Pharmacist Counselling Style In Australia

Use a documented, evidence‑based approach: confirm cardiac and psychiatric history, check current medicines for nitrates, SSRIs, MAOIs or strong CYP3A4 inhibitors, and discuss timing and alcohol avoidance.

Advise patients to take one tablet 30–60 minutes before sexual activity, not to exceed one dose in 24 hours, and to report adverse effects to the TGA if suspected.

If a patient presents with an imported product, verify packaging shows vardenafil with dapoxetine and the correct strengths, counsel on authenticity risks and arrange follow‑up within 1–2 weeks.

National Health Authority Recommendations

Because the fixed combo lacks TGA central approval, national guidance supports using individual regulated agents where titration is required and documenting informed consent for off‑label or imported use.

Delivery Across Australia

Concluding Practical Notes

Many men want a simple, one‑tablet approach for both ED and PE and vardenafil with dapoxetine tablets marketed as Super Vilitra respond to that need in some countries.

Clinicians in Australia should balance convenience against the lack of TGA registration for fixed combos and prefer regulated individual prescriptions when dose flexibility or safety monitoring is necessary.

Community pharmacists are essential in screening for nitrates and interacting medicines, counselling on timing and alcohol restriction, and reporting adverse events to the TGA.

Patients importing combination tablets should be counselled on storage, authenticity checks and the need to seek prompt medical care for severe side effects such as chest pain, severe dizziness or priapism.

Storage And Transport Quick Checklist

• Store below 30°C and protect from moisture and light.
• Keep in original blister pack and check expiry before use.
• Avoid leaving tablets in cars during hot weather or in bathrooms where humidity is high.
• Pharmacies should inspect shipments for tampering and record batch numbers.

Guidelines For Pharmacists

Always confirm cardiovascular history and current medicines including nitrates, SSRIs, MAOIs and CYP3A4 inhibitors before dispensing.

Explain timing (take one tablet 30–60 minutes before sex), contraindications and the single‑dose daily limit.

Document counselling, obtain informed consent for off‑label or imported use, and arrange follow‑up within 1–2 weeks to assess efficacy and adverse effects.

Final Frequently Asked Questions

Q: Can the tablet be used recreationally or by men without diagnosed sexual dysfunction?

A: No. These medicines are intended for clinical indications and carry safety risks if used recreationally or without medical supervision.

Q: What should I do if I experience prolonged erection or severe dizziness?

A: Seek immediate medical attention for priapism or symptoms of severe hypotension such as fainting, chest pain or severe dizziness.

Q: Who should I contact to report adverse events?

A: Adverse events in Australia should be reported to the TGA’s Database of Adverse Event Notifications; pharmacists can assist patients with reporting.